Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055)

Clinical trial NCT01014013 · COMPLETED

Trial details

NCT number: NCT01014013
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Urinary Tract Infection

Start date: 2008-04-01
Primary completion: 2009-02-01
Enrollment: 271

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.